Cannabinoid Receptor 2 (CB₂) Signals via G-alpha-s and Induces IL-6 and IL-10 Cytokine Secretion in Human Primary Leukocytes

Abstract

Cannabinoid receptor 2 (CB2) is a promising therapeutic target for immunological modulation.There is, however, a deficit of knowledge regarding CB2 signaling and function in human primary immunocompetent cells. We applied an experimental paradigm which closely models the in situ state of human primary leukocytes (PBMC; peripheral blood mononuclear cells) to characterize activation of a number of signaling pathways in response to a CB2-selective ligand (HU308). We observed a "lag" phase of unchanged cAMP concentration prior to development of classically-expected Gαi-mediated inhibition of cAMP synthesis. Application of G protein inhibitors revealed that this apparent lag was a result of counteraction of Gαi effects by concurrent Gαs activation. Monitoring downstream signaling events, activation of p38 was mediated by Gαi whereas ERK1/2 and Akt phosphorylation were mediated by Gαi-coupled βγ.Activation of CREB integrated multiple components; Gαs and βγ mediated ~85% of the response, while ~15% was attributed to Gαi. Responses to HU308 had an important functional outcome -secretion of interleukins 6 (IL-6) and 10 (IL-10). IL-2, IL-4, IL-12, IL-13, IL-17A, MIP-1α, and TNF-α were unaffected. IL-6/IL-10 induction had a similar G protein coupling profile to CREB activation. All response potencies were consistent with that expected for HU308 acting via CB2. Additionally, signaling and functional effects were completely blocked by a CB2selective inverse agonist, giving additional evidence for CB2 involvement. This work expands the current paradigm regarding cannabinoid immunomodulation and reinforces the potential utility of CB2 ligands as immunomodulatory therapeutics.Keywords: cannabinoid receptor 2 (CB2), G protein-coupled receptor (GPCR), signaling, leukocytes, interleukin 6, interleukin 10 Significance statementCannabinoid receptor 2 (CB2) is a G protein-coupled receptor which plays a complex role in immunomodulation and is a promising target in a range of disorders with immune system involvement. However, to date the majority of the studies in this field have been performed on cell lines, rodent models, or stimulated primary cells. Here we provide a detailed account of CB2-mediated signaling in primary human immune cells under conditions which closely mimic their in vivo state. We reveal a complex signaling system involving an unprecedented CB2 signaling pathway and leading to immunomodulatory functional outcomes. This work provides not only a critical foundation impacting CB2-targeted drug discovery, but reveals important wider considerations for GPCR signaling studies and model validity.

Trophoblast derived extracellular vesicles specifically alter the transcriptome of endometrial cells and may constitute a critical component of embryo-maternal communication

“…GPCRs are the largest family of transmembrane receptors accounting for 4% of the coding regions of the human genome [68]. They are known to bind a highly diverse set of ligands that perform biological functions ranging from sight and olfactory senses to immune regulation [69,70]. They also act as receptors for a number of ligands known to alter the endometrial microenvironment during the WOI [71], such as hCG [72], prostaglandin E2 [73,74], cytokines [75][76][77] and progesterone via its membrane bound receptor [78][79][80].…”

<p>Cannabidiol as a Novel Therapeutic for Immune Modulation</p>

“…As a result, intracellular signal transduction, and protein kinase A (PKA) activity is hindered. [16][17][18] The cAMP-PKA signal transduction is crucial for many cellular responses including enzyme activation and gene expression. 19 Studies have also shown that activation of the CB 1 receptor also leads to regulation of mitogen-activated protein kinases (MAPKs) that are vital to inflammatory and immune cellular responses, including extracellular signalregulated protein kinase 1/2 (ERK1/2), p38, and c-jun terminal kinase (JNK).…”

The Dynamic Role of Microglia and the Endocannabinoid System in Neuroinflammation

“…Cannabinoid receptors are G protein-coupled receptors (GPCRs) that typically couple to Gα i but have been observed to couple to Gα o and Gα s under some circumstances (Glass and Felder, 1997;Howlett et al, 2002;Saroz et al, 2019). CB 1 receptors are abundant in central neurons and inhibit transmitter release upon activation (Howlett et al, 2002).…”